Testosterone Cypionate Month-by-Month: What Actually Happens in the First 3 Months

Is there a month-by-month timeline?

The Depo-Testosterone label gives dosing and half-life, not a symptom timeline. [2]

The label's replacement dose is 50 to 400 mg every 2 to 4 weeks, given deep in the gluteal muscle and never intravenously. The half-life after intramuscular injection is about 8 days. [2]

What effects are documented?

Hematocrit is the best-documented change. A 2022 network meta-analysis of 29 placebo-controlled trials (3,393 men) found intramuscular enanthate or cypionate raised mean hematocrit by 4.0% versus placebo (95% CI 2.9 to 5.1). [1] A retrospective review of 178 men followed for 3 years found erythrocytosis (hematocrit above 50%) in 66.7% on injectables versus 12.8% on gels. The injection group was younger, had higher baseline hematocrit, and the study was not randomized. [6]

Blood pressure can rise. The cypionate label says testosterone can increase blood pressure, which can increase cardiovascular risk over time, that blood pressure should be measured periodically, and that testosterone products are not recommended in uncontrolled hypertension. [2] FDA says ambulatory blood pressure studies confirmed an increase with all testosterone products. [3] The same label still says studies have been inconclusive on major adverse cardiovascular events, and that some studies, but not all, have reported increased risk. [2]

Fertility effects are label-documented. Exogenous testosterone inhibits pituitary luteinizing hormone and, at large doses, follicle-stimulating hormone, which may suppress sperm production. [2] The label lists oligospermia at high dosages. [2]

What does the label say to monitor?

The label says to check hemoglobin and hematocrit periodically in long-term use and to measure blood pressure periodically. [2] It notes that geriatric patients treated with androgens may be at increased risk of prostatic hypertrophy and prostatic carcinoma, although conclusive evidence is lacking. [2] It lists gynecomastia, acne, injection-site pain, headache, anxiety, depression, and libido changes as possible reactions, not as a schedule. [2]

What does indirect, longer-term evidence show?

Neither study below tested cypionate replacement over the first 3 months. A 20-week dose-response study gave weekly testosterone enanthate to healthy young men whose own testosterone was suppressed. Fat-free mass rose 3.4 kg at 125 mg/week, 5.2 kg at 300 mg/week, and 7.9 kg at 600 mg/week. [7] The Testosterone Trials gave a gel for 1 year to men 65 and older with low testosterone. They found a moderate benefit for sexual function, some benefit for mood and depressive symptoms, and no benefit for vitality or walking distance. [8]